MesenSistem-EB: systemic haploidentical mesenchymal stem cell therapy in recessive dystrophic epidermolysis bullosa associated with clinical benefits and correlated with MCP1 and sCD40L dynamics
-
By
-
Rocío Maseda
-
María Carmen Arriba
-
Lucía Martínez-Santamaría
-
Eva Jiménez
-
Sara Herráiz-Gil
-
Nuria Illera
-
Lucía Quintana-Castanedo
-
Marta García
-
Susana Suárez-Sancho
-
Rosa Yáñez
-
Isabel Pérez-Conde
-
Marta Carretero
-
Magdalena Martínez-Queipo
-
Raquel de Paz
-
Carlos León
-
Víctor Jiménez-Yuste
-
Alberto M. Borobia
-
Ángeles Vicente
-
Su M. Lwin
-
John A. McGrath
-
María Eugenia Fernández-Santos
-
Nora Butta
-
Rosa Sacedón
-
Marcela del Río
-
Raúl de Lucas
-
María José Escámez
-
May 5, 2026
-
0 min
Top Institutions in Oncology
Brief introduction explaining scope and methodology.
-
#1
Leiden University Medical Center
Leiden, South Holland
-
#2
University of Pavia
Pavia, Lombardy
-
#3
University of Freiburg
Freiburg, Baden-Württemberg
-
#4
University of Tübingen
Tübingen, Baden-Württemberg
-
#5
University of Perugia
Perugia, Umbria
